Pediatric Vaccines Global Market by Vaccines type & Data Validation, Analysis and Forecast 2022
ReportsWeb.com published “Pediatric Vaccines Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, June 12, 2017 ) Rising government and non-government financial support for development of vaccine is the major driver for the pediatric vaccine market. Increasing innovative technologies such as therapeutic and adjuvant vaccines are anticipated to fuel the pediatric vaccine market during the forecast period. Moreover, increasing expenditure of vaccines, little accessibility to remote areas and strict regulation for approval of vaccines are some of the factors hampering the global pediatric vaccine market.
Infectious diseases segment is expected to grow at a faster rate during the forecast period. North America dominates the global market for pediatric vaccines followed by Europe. Moreover, the Asia Pacific is likely to report the highest CAGR during the forecast period, driven by the high birth rate in China and India.
For more information @ http://www.reportsweb.com/pediatric-vaccines-global-market-outlook-2015-2022
Some of the key players in the market include Johnson and Johnson, Abbott Laboratories, Baxter International, Eli Lilly and Company, Sanofi S.A, Novo Nordisk A/S, Bharat Biotech International Limited, Actelion Pharmaceuticals Ltd, Genentech, Inc., Shire Pharmaceuticals Group Plc, Merck & Co. Inc, Bristol-Myers Squibb Company, Amgen Inc., Novartis AG and Boehringer Ingelheim GmbH.
Diseases type Covered:
- Cancer and allergy
- Infectious disease
- Pneumococcal disease
- Influenza
- Diphtheria
- Rotavirus
- Tetanus
- Haemophilus Influenzae type b (Hib)
- Meningococcal
- Hepatitis A
- Hepatitis B
- Rubella
- Mumps
- Measles
- Pertussis
- Varicella (chickenpox)
- Polio
Products Covered:
- Anti-infective drugs
- Pediatric hormones
- Allergy & respiratory drugs
- CNS drugs
Vaccines type Covered:
- Synthetic vaccines
- Conjugate vaccines
- Live attenuated vaccines
- Dendritic cells vaccines
- Toxoid vaccines
- Recombinant vector vaccines
- Subunit vaccines
- Inactivated vaccines
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216352/sample
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
10 Company Profiling
10.1 Johnson and Johnson
10.2 Abbott Laboratories
10.3 Baxter International
10.4 Eli Lilly and Company
10.5 Sanofi S.A
10.6 Novo Nordisk A/S
10.7 Bharat Biotech International Limited
10.8 Actelion Pharmaceuticals Ltd
10.9 Genentech, Inc.
10.10 Shire Pharmaceuticals Group Plc
10.11 Merck & Co. Inc
10.12 Bristol-Myers Squibb Company
10.13 Amgen Inc.
10.14 Novartis AG.
10.15 Boehringer Ingelheim GmbH
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216352/buying
Infectious diseases segment is expected to grow at a faster rate during the forecast period. North America dominates the global market for pediatric vaccines followed by Europe. Moreover, the Asia Pacific is likely to report the highest CAGR during the forecast period, driven by the high birth rate in China and India.
For more information @ http://www.reportsweb.com/pediatric-vaccines-global-market-outlook-2015-2022
Some of the key players in the market include Johnson and Johnson, Abbott Laboratories, Baxter International, Eli Lilly and Company, Sanofi S.A, Novo Nordisk A/S, Bharat Biotech International Limited, Actelion Pharmaceuticals Ltd, Genentech, Inc., Shire Pharmaceuticals Group Plc, Merck & Co. Inc, Bristol-Myers Squibb Company, Amgen Inc., Novartis AG and Boehringer Ingelheim GmbH.
Diseases type Covered:
- Cancer and allergy
- Infectious disease
- Pneumococcal disease
- Influenza
- Diphtheria
- Rotavirus
- Tetanus
- Haemophilus Influenzae type b (Hib)
- Meningococcal
- Hepatitis A
- Hepatitis B
- Rubella
- Mumps
- Measles
- Pertussis
- Varicella (chickenpox)
- Polio
Products Covered:
- Anti-infective drugs
- Pediatric hormones
- Allergy & respiratory drugs
- CNS drugs
Vaccines type Covered:
- Synthetic vaccines
- Conjugate vaccines
- Live attenuated vaccines
- Dendritic cells vaccines
- Toxoid vaccines
- Recombinant vector vaccines
- Subunit vaccines
- Inactivated vaccines
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216352/sample
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
10 Company Profiling
10.1 Johnson and Johnson
10.2 Abbott Laboratories
10.3 Baxter International
10.4 Eli Lilly and Company
10.5 Sanofi S.A
10.6 Novo Nordisk A/S
10.7 Bharat Biotech International Limited
10.8 Actelion Pharmaceuticals Ltd
10.9 Genentech, Inc.
10.10 Shire Pharmaceuticals Group Plc
10.11 Merck & Co. Inc
10.12 Bristol-Myers Squibb Company
10.13 Amgen Inc.
10.14 Novartis AG.
10.15 Boehringer Ingelheim GmbH
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216352/buying
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results